Calls Purchased on Jazz Pharmaceuticals (JAZZ)

Shares of Jazz Pharmaceuticals JAZZ are lower on the session by 0.15%, currently trading at $19.80. The stock has been moving largely higher over the past six months is currently trading above the 200-day moving average. Options traders are buying calls on the name today. Though action has been primarily in small lots, overall call volume is now running at 4.15x the daily average with 94% of all calls traded being purchases on the offer. Traders are buying the $19.00, $20.00, and $21.00 strikes in January 2011. Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on the development and commercialization of pharmaceutical products to meet unmet medical needs in neurology and psychiatry.